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Background/aim: The aim of this study was to investigate the effect of vitamin D supplementation on ambulation and mobility in
hospitalized patients undergoing stroke rehabilitation.
Materials and methods: This study was conducted retrospectively between September 2020 and October 2020 at Gazi University
Faculty of Medicine Physical Medicine and Rehabilitation Department. Seventy-six patients who received inpatient stroke rehabilitation
treatment between May 2018 and February 2020 were included in the study. The patients were divided into two groups as those who
did and did not take vitamin D supplements. Lower extremity motor function and ambulation status were compared using Brunnstrom
recovery stage (lower extremity) and functional ambulation classification (FAC) scores before and after rehabilitation.
Results: Thirty-nine patients received vitamin D treatment during the rehabilitation process and 37 patients did not. The two groups
were similar in terms of age, sex, time since stroke, stroke type, comorbid diseases, nutritional status, rehabilitation duration, and FAC
and Brunnstrom scores before rehabilitation (p > 0.05). At the end of rehabilitation, the changes in FAC and Brunnstrom scores were
higher in patients receiving vitamin D supplementation (p = 0.005 and p = 0.018). The change in FAC and Brunnstrom scores in patients
who were undergoing rehabilitation for the first time and/or in the first 3 months after stroke was higher in the group receiving vitamin
D supplementation compared with the group not receiving vitamin D (p < 0.05). In patients who were not within the first 3 months after
stroke, vitamin D treatment did not affect FAC and Brunnstrom scores.
Conclusion: Vitamin D supplementation may increase the success of rehabilitation therapy in patients during the first 3 months
poststroke.
Key words: Stroke rehabilitation, vitamin D, brunnstrom recovery stage, functional ambulation

1. Introduction
Stroke is one of the most common causes of mortality
and long-term disability [1]. The risk of life-long stroke in
adult women and men is approximately 25% [2]. Advances
in acute stroke treatment have increased the survival
rates after stroke. Patients with stroke need rehabilitation
due to different rates of disability [3]. After treatment of
acute stroke, physical rehabilitation is an important part
of stroke management and is necessary to compensate
for disabilities and to maximize functional performance.
Many factors affect the success of rehabilitation treatment.
Regardless of the cause of the stroke, factors such as
patient age, stroke severity, comorbid diseases, degree of
the deficit, and the nutritional status of the patient affect
poststroke rehabilitation success.
Vitamin D deficiency is very common in Turkish
society (73.9%) [4]. Vitamin D deficiency is a common
problem in patients with stroke, and its prevalence in this

patient group is about 71% [5]. Common causes of vitamin
deficiency in patients with stroke are malnutrition,
immobility, and insufficient sunlight exposure. Low serum
vitamin D levels in these patients cause musculoskeletal
problems and recent studies demonstrated that it also
increased stroke severity, disability, cerebrovascular
accidents, and cardiovascular death and mortality [6].
Vitamin D is very important for nervous system
functions. It has a significant neuroprotective effect
as a neurosteroid, and vitamin D receptors are widely
expressed in neuronal and glial cells. Vitamin D increases
neurotrophin production and secretion; it is involved
in the synthesis of neuromediators and intracellular Ca
homeostasis and prevention of oxidative damage in nerve
tissue. In clinical studies, the frequency of some central
nervous system diseases (schizophrenia and multiple
sclerosis) has been shown to increase with vitamin D
deficiency [7]. In a metaanalysis, it was reported that

* Correspondence: aycautkan@gazi.edu.tr

This work is licensed under a Creative Commons Attribution 4.0 International License.

1413

UTKAN KARASU and KAYMAK KARATAŞ / Turk J Med Sci
dementia is more common in vitamin D deficiency [8].
The correlation between neurodegenerative diseases
and vitamin D deficiency may be related to the role
of vitamin D in the regulation of nerve growth factor
synthesis. Dysregulation of neuronal Ca levels negatively
affects neuronal functions [9]. Vitamin D is important
for the development and differentiation of neuronal
cells. Vitamin D is also a micronutrient that acts as an
antioxidant in the central nervous system. Calcitriol
increases iNOS synthesis and the amount of glutathione
in the central nervous system. Thus, it reduces oxidative
stress and provides vasodilation [10]. Its role in Ca
metabolism makes vitamin D important for the control
of the relaxation response of striated muscle. In vitamin
D deficiency, oxidative stress increases in striated muscle,
and mitochondrial dysfunction increases and muscle
atrophy may be observed [11]. Because of these effects of
vitamin D on nervous and musculoskeletal systems, it is
reasonable to expect adequate vitamin D levels and proper
supplementation will have positive effects on poststroke
rehabilitation.
In the literature, there are contradictory results
in studies that investigated the effect of vitamin D
supplementation on poststroke rehabilitation [12,13].
The aim of the current study was to compare the lower
extremity motor function and ambulation gains obtained
with poststroke rehabilitation in patients with stroke who
received vitamin D supplementation.
2. Materials and methods
The study was conducted retrospectively between
September 2020 and October 2020 at Gazi University
Faculty of Medicine Physical Medicine and Rehabilitation
Department. The study protocol was approved by the
Gazi University Faculty of Medicine ethics committee
(Decision Number: 559). Seventy-six patients who
received inpatient stroke rehabilitation treatment between
May 2018 and February 2020 were included in the study.
The demographic and clinical data of the patients were
collected by reviewing electronic and physical patient files.
Patients who had stroke for the first time were enrolled
in the study. Physical examination and imaging methods
[computed tomography (CT), magnetic resonance imaging
(MRI)] were used for differential diagnosis. The exclusion
criteria were: (1) absence of prerehabilitation vitamin D
level measurement, (2) having chronic kidney, liver, or
lung diseases that might interfere with vitamin D levels,
(3) being on a current steroid treatment, and (4) previous
history of orthopedic problems known to affect lower
extremity functions. Patients’ age, sex, time elapsed from
the onset of stroke to the start of rehabilitation, duration
of rehabilitation, type of stroke, comorbid diseases, and
nutritional status were recorded. 25-hydroxyvitamin D
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(25(OH)D) serum levels measured as ng/mL in the first
week after hospitalization were recorded. Lower extremity
motor function and ambulation were evaluated using
Brunnstrom Recovery Stage (BRS) (lower extremity)
and functional ambulation classification (FAC). The BRS
assessment scores the clinical severity of hemiplegia from
1 to 6. A score of 1 indicates paralysis and 6 indicates
normal force and function [14]. FAC evaluates ambulation
in 6 categories ranging from 0 to 5. A score of 0 means
that the patient is not ambulatory, and 5 indicates normal
ambulation [15]. The patients included in the study were
divided into two groups as those who received vitamin D
treatment during the rehabilitation period and those who
did not. Weekly vitamin D (50,000 IU) support for 4–12
weeks was given to patients orally during the rehabilitation
period and the total vitamin D dose ranged from 200,000
to 600,000 IU. Vitamin D levels before rehabilitation,
BRS and FAC scores, and changes in BRS and FAC scores
before and after rehabilitation were compared between the
two groups.
SPSS v 22 (IBM Corp., Armonk, NY, USA) data
analysis program was used for statistical analysis. For
comparison of demographic features, the Mann–Whitney
U test was used for nonparametric continuous variables,
and the chi-square test was used for discrete variables. In
the presentation of statistical data, continuous variables
are expressed as median, minimum–maximum values,
and discrete variables as percentages. A p-value of less
than 0.05 was considered to be statistically significant.
3. Results
There were 76 patients enrolled in the study. Thirtyseven (49%) of these patients did not receive vitamin D
treatment during rehabilitation and 39 (51%) did. Some
of the demographic characteristics of the patients are
summarized in Table 1.
Prerehabilitation vitamin D levels of patients are
summarized in Figure. There were four patients with
normal vitamin D levels (5.3%). The median value of
vitamin D levels of all patients before rehabilitation
treatment was 17 ng/mL (8–41).
In 32% of patients (n = 24), the time elapsed after the
stroke was less than 3 months. This period was more than
3 months in 68% (n = 52).
The comparison of FAC and BRS scores of patients
who did and did not receive vitamin D treatment during
the rehabilitation process is shown in Table 2. There was
no statistically significant difference in the initial FAC and
BRS scores between those who did and did not receive
vitamin D treatment during rehabilitation (p = 0.872 and p
= 0.906). Postrehabilitation FAC and BRS scores were also
similar in both groups (p = 0.151 and p = 0.153). However,
the change in FAC and BRS scores after rehabilitation
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Table 1. Demographic data and clinical characteristics of the
patients.

Age (years)

Table 2. Effect of vitamin D treatment on ambulation and lower
extremity motor function.

Vitamin D

Vitamin D

Control (n = 37) Vitamin D (n = 39) p–value

Control (n = 37)

Vitamin D (n = 39) p-value

Prerehab

3 (1–5)

2 (0–4)

0.872

Postrehab

3 (0–5)

3 (0–5)

0.151

Change

0 (0–3)

1 (0–4)

0.005

60 (14–89)

64 (25–83)

0.917

Female

16 (21%)

26 (34%)

0.069

Male

21 (28%)

13 (17%)

Sex

Stroke

FAC

BRS

Hemorrhagic

10 (13%)

6 (8%)

Prerehab

2 (0–6)

4 (1–6)

0.906

Ischemic

23 (30%)

30 (39%)

0.365

Postrehab

4 (1–6)

5 (1–6)

0.153

Tumor

4 (5%)

3 (4%)

0.018

4 (0.5–72)

3 (0.5–156)

Change
0 (0–2)
Vitamin D*
levels (ng/ 18 (8–41)
mL)

1 (0–5)

Stroke–
rehabilitation
interval
(months)

15 (8–36)

0.330

0.975

Stroke
Subacute
(1–4 week)

12 (16%)

12 (16%)

Chronic
(>4 week)

25 (33%)

27 (36%)

Right

18 (24%)

19 (25%)

Left

19 (25%)

18 (24%)

Bilateral

0

2 (2%)

Yes

14 (18%)

11 (14%)

No

23 (30%)

28 (37%)

0.876

Side
0.367

Previous rehab

Rehabilitation
43 (22–90)
duration(days)

43 (22–90)

0.372

0.451

Vitamin D Status
5%

13%

28%

54%

Severe Deficiency (<10 ng/mL)

Deficiency (10-20 ng/mL)

Insufficiency (20-30 ng/mL)

Normal (>30 ng/mL)

Figure. Distribution of patients’ vitamin D levels.

Values are presented as median (min–max).
FAC: functional ambulation classification, BRS: Brunnstrom
recovery stage.
*25(OH)D: 25-hydroxy vitamin D.

treatment was higher in the group receiving vitamin D (p
= 0.005 and p = 0.018).
When the patients who received rehabilitation
treatment for the first time were examined (n = 51), no
difference was observed between the two groups in
terms of pre- and postrehabilitation FAC and BRS scores
(p > 0.05). However, the FAC and BRS score changes
after rehabilitation treatment were statistically different
between the two groups (p = 0.035 and p = 0.024). The
improvement in these evaluations was higher in the group
receiving vitamin D treatment. The initial vitamin D levels
were similar in these patients (p = 0.543) [controls: 18
(8–41) ng/mL and Vitamin D: 15 (8–28) ng/mL] (Table 3).
In previously rehabilitated patients (n = 25), FAC and
BRS scores before and after rehabilitation and changes in
these scores were similar (p > 0.05). Initial vitamin D levels
were also similar in these patients (p = 0.564) (Table 4).
The effects of vitamin D treatment on FAC and
BRS scores were compared in the patients who started
rehabilitation treatment in the first 3 months after stroke.
The change in FAC and BRS scores was found to be
statistically significant in patients receiving vitamin D
treatment (p = 0.005 and p = 0.047) (Table 5).
In patients who were not within the first 3 months after
stroke, vitamin D treatment had no effect on FAC and BRS
scores (p > 0.05) (Table 6).
4. Discussion
In this clinical trial, it was observed that vitamin D
supplementation during stroke rehabilitation might have
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Table 3. The effect of vitamin D therapy on ambulation and lower
extremity motor function in patients undergoing rehabilitation
for the first time.

Table 5. The effect of vitamin D treatment on ambulation and
lower extremity motor function in patients with stroke in the first
3 months after stroke.

Vitamin D

Vitamin D

Control (n = 23) Vitamin D (n = 28) p–value

Control (n = 22) Vitamin D (n = 16) p-value

FAC

FAC

Prerehab

2 (0–5)

2 (0–4)

0.842

Prerehab

1.5 (0–5)

1 (0–4)

0.795

Postrehab

3 (0–5)

3 (0–5)

0.366

Postrehab

2.5 (0–5)

4 (1–5)

0.251

Change

0 (0–3)

1 (0–4)

0.035

Change

0 (0–3)

2 (0–5)

0.005

Prerehab

3 (1–6)

4 (1–6)

0.855

Prerehab

3.5 (1–6)

3,5 (1–6)

0.978

Postrehab

4 (1–6)

5 (1–6)

0.213

Postrehab

4.5 (1–6)

5 (2–6)

0.171

Change

0 (0–2)

1 (0–5)

0.024

1 (0–5)

0.047

15 (8–36)

0.543

Change
0 (0–2)
Vitamin D*
17.5 (8–26)
levels (ng/mL)

13 (8–36)

0.200

BRS

BRS

Vitamin D*
18 (8–41)
levels (ng/mL)

Values are presented as median (min–max).
FAC: functional ambulation classification, BRS: Brunnstrom
recovery stage.
*25(OH)D: 25-hydroxy vitamin D.
Table 4. The effect of vitamin D treatment on ambulation and
lower extremity motor function in patients who had received
previous rehabilitation treatment.

Values are presented as median (min–max).
FAC: functional ambulation classification, BRS: Brunnstrom
recovery stage.
*25(OH)D: 25-hydroxy vitamin D.
Table 6. Effect of vitamin D treatment on ambulation and lower
extremity motor function in patients with stroke who were not
within the first 3 months of stroke.

Vitamin D

Vitamin D

Control (n = 14) Vitamin D (n = 11) p–value

Control (n = 19) Vitamin D (n = 19) p-value

FAC

FAC

Prerehab

3 (0–4)

3 (0–4)

0.602

Prerehab

3 (0–4)

3 (0–4)

0.692

Postrehab

3 (2–4)

4 (2–5)

0.114

Postrehab

3 (0–5)

3 (0–5)

0.441

Change

0 (0–1)

1 (0–3)

0.176

Change

0 (0–3)

1 (0–3)

0.311

Prerehab

3 (2–6)

3 (2–5)

0.841

Prerehab

3 (1–6)

4 (1–6)

0.999

Postrehab

3 (2–6)

3 (2–6)

0.799

Postrehab

4 (1–6)

5 (1–6)

0.580

0 (0–1)

0.507

Change

0 (0–2)

0 (0–3)

0.169

0.564

Vitamin D*
20 (8–41)
levels (ng/mL)

19 (8–35)

0.759

BRS

BRS

Change
0 (0–2)
Vitamin D*
21 (11–36)
levels (ng/mL)

19 (8–36)

Values are presented as median (min–max).
FAC: functional ambulation classification, BRS: Brunnstrom
recovery stage.
*25(OH)D: 25-hydroxy vitamin D.

Values are presented as median (min–max).
FAC: Functional ambulation classification, BRS: Brunnstrom
recovery stage.
*25(OH)D: 25-hydroxy vitamin D.

positive effects on ambulation and lower extremity motor
functions. The positive change in FAC and BRS scores
in patients receiving vitamin D treatment was found to
be statistically significant (p > 0.05). There are studies in
the literature investigating the effect of patient vitamin D
levels on rehabilitation success. We think that this study is

valuable in terms of investigating the effect of vitamin D
supplementation given during rehabilitation.
The effect of vitamin D levels on the functional outcomes
of rehabilitation has been studied in many different disease
groups such as spinal cord injury, fibromyalgia, and stroke
[16–18]. Liu et al. conducted a metaanalysis investigating
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the effect of serum vitamin D level on functional results in
patients with stroke; they examined 10 studies including
6845 patients with stroke and concluded that vitamin D
deficiency affected functional gains negatively [18]. There
are also studies reporting that vitamin D deficiency is a
predictor of overall prognosis in patients with stroke and
increases morbidity and mortality [19–21]. On the other
hand, there are contradictory results regarding the effect
of vitamin D supplementation in the rehabilitation success
of patients with stroke. In a randomized controlled trial,
Momosaki et al. compared placebo with 2000 IU/day
vitamin D treatment given during 8 weeks’ rehabilitation
treatment of patients with acute stroke. Functional
outcomes before and after rehabilitation were evaluated
using the Barthel index and Brunnstrom motor recovery
stage and it was reported that vitamin D supplementation
did not improve functional gains [12]. However, a relatively
low dose of vitamin D was used in this study. Therefore,
adequate vitamin D levels may not have been reached and
the desired effect may not have been observed. Gupta et
al. evaluated the effect of high-dose vitamin D treatment
(600,000 IU) on functional gains using modified Rankin
scores in patients with acute stroke with low vitamin D
levels and stated that functional gains were better in those
receiving vitamin D support [13].
In the general population, it is recommended to
provide weekly vitamin D (50,000 IU) support for 8–12
weeks in the treatment of severe vitamin D deficiency
[22]. As far as we know, a special vitamin D treatment
regimen recommended for patients with stroke with
vitamin D deficiency is not available. Narasimhan et al.
compared the rehabilitation success between patients
receiving 600,000 IU cholecalciferol supplementation and
patients without vitamin D supplementation using the
Scandinavian stroke scale in patients with ischemic stroke.
It was reported that there was a significant improvement
in stroke outcomes after 3 months in patients who were
supplemented with vitamin D [23]. Sarı et al. administered
300,000 IU cholecalciferol (IM) at the beginning of
rehabilitation in chronic stroke patients and investigated
its effect on rehabilitation outcomes using BRS, FAC, the
modified Bartel index, and Berg balance scale (BBS) at the
beginning of rehabilitation and 3rd month of vitamin D
administration. It was reported that vitamin D treatment
increased activity levels and accelerated balance recovery,
but did not significantly affect ambulation or motor
recovery [24]. The results obtained by Sarı et al. regarding
ambulation and motor recovery are different from those
obtained in our study. This may be due to the fact that the
patients included in the study were not within the first
3 months after stroke and in our study, oral vitamin D
treatment was given to patients during the rehabilitation
period and the total vitamin D dose ranged from 200,000

to 600,000 IU. In our study, the changes in BRS and FAC
scores evaluating functional activity in patients receiving
vitamin D treatment were found to be better in the group
of patients who were rehabilitated for the first time. The
change in BRS and FAC scores was higher in patients who
started rehabilitation in the first 3 months after stroke and
received vitamin D treatment. This effect was not observed
in those who had previously received rehabilitation
treatment. There was no significant difference in BRS and
FAC scores in patients who started rehabilitation after the
3rd month of stroke. Most of the functional motor gains
in patients with stroke occur in the first 3 months after
stroke [25]. For this reason, vitamin D treatment may not
have contributed to the changes in BRS and FAC scores in
patients within the chronic period and patients who had
previously received rehabilitation. We think that vitamin
D treatment is beneficial and important, especially in
patients who are in the first 3 months after stroke and who
are rehabilitated for the first time.
The most important limitations of this study are
its retrospective design and the fact that vitamin D
supplementation has not been used in different treatment
regimens and doses. We think that there is a need for
randomized controlled studies investigating the effects
of different doses of vitamin D treatment. Another
limitation is that only the FAC and BRS stages are used as
the outcome measures to assess ambulation and mobility.
Due to the retrospective design of the study, scales such
as Functional Independence Measure and BBS, which
can provide information about general functional gains
and balance, could not be used. Another limitation of
the study is the lack of knowledge about whether patients
with previous rehabilitation treatment were evaluated
for vitamin D levels during their previous rehabilitation
treatment and whether these patients received vitamin D
support. One of the reasons for not observing the effect
of vitamin D supplementation in these patients in the
chronic phase may be due to the fact that the maximum
recovery expected in these patients has already occurred
in the first 3 months, which are critical. However, we think
that it is important that vitamin D supplementation has a
positive effect on BRS and FAC score changes in patients
who are in the first 3 months after stroke and who have not
received any rehabilitation before.
As a result, we think that vitamin D supplementation
in patients with stroke may increase rehabilitation success,
especially in patients who are in the first 3 months after
stroke and who will receive rehabilitation treatment for the
first time.
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